✦ LIBER ✦

P563 Clinical response and quality of life in patients with Crohn's disease treated with adalimumab in routine clinical practice

✍ Scribed by Ceballos, D.; Muñoz, F.; Saro, C.; De la Coba, C.; Aguilar, M.D.; Lazaro, P.

Book ID: 122931671
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 54 KB
Volume: 7
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(13)60584-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P564 Clinical response, quality of life

P564 Clinical response, quality of life and work activity in patients with Crohn's disease treated with adalimumab in routine clinical practice

✍ Saro, C.; Ceballos, D.; Muñoz, F.; De la Coba, C.; Aguilar, M.D.; Lazaro, P. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 65 KB

P573 Changes in resource utilisation in

P573 Changes in resource utilisation in patients with Crohn's disease treated with adalimumab in routine clinical practice

✍ Saro, C.; Ceballos, D.; Muñoz, F.; De la Coba, C.; Aguilar, M.D.; Lazaro, P. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 52 KB

W1108 Remission, Response, and Quality-o

W1108 Remission, Response, and Quality-of-Life Improvement in Patients with Crohn's Disease Treated with Adalimumab in the Access Trial

✍ Rutgeerts, Paul; Loftus, Edward V.; Binion, David G.; McHugh, Kevin; Chen, Naiju 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Adalimumab safety in global clinical tri

Adalimumab safety in global clinical trials of patients with Crohn's disease

✍ Jean-Frédéric Colombel; William J. Sandborn; Remo Panaccione; Anne M. Robinson; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 2 views

Background: Adalimumab, a fully human anti-tumor necrosis factor (anti-TNF) monoclonal antibody, is approved for the treatment of Crohn's disease (CD) in adults. We evaluated the overall safety profile of adalimumab in global clinical trials in patients with CD. Patients who participated in these tr

P244 Factors associated with the improve

P244 Factors associated with the improvement of quality of life among Crohn's disease patients treated with adalimumab

✍ J. Mudter; M.F. Neurath; P. von Arnauld de la Perriére; N. Teich; H. Hartmann; G 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 64 KB

Quality of life in patients with treated

Quality of life in patients with treated and clinically stable Wilson's disease

✍ Marina Svetel; Tatjana Pekmezović; Aleksandra Tomić; Nikola Kresojević; Aleksand 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Abstract Health‐related quality of life (HRQoL) in Wilson's disease (WD) has not been extensively studied. Therefore, the purpose of this cross‐sectional study was to identify clinical and demographic factors influencing HRQoL in 60 treated, clinically stable patients with WD using a generic que